CBIO financial statements and SEC filings

CBIO annual income statement

Fiscal period endRevenueOperating incomeNet incomeSEC filing
2025-12-31$10.84M-$152.63M-$133.45M10-K
2024-12-31–-$40.04M-$37.88M10-K
2023-12-31$10.00K-$39.28M-$36.90M10-K
2022-12-31$75.00K-$47.40M-$46.69M10-K
2021-12-31$1.16M-$63.45M-$63.43M10-K
2020-12-31$10.16M-$51.51M-$51.03M10-K

CBIO annual balance sheet

Fiscal period endAssetsLiabilitiesEquitySEC filing
2025-12-31$240.29M$37.28M$203.01M10-Q
2024-12-31$35.62M$47.10M-$15.48M10-K
2023-12-31$45.32M$6.90M$38.41M10-K
2022-12-31$51.81M$8.88M$42.93M10-K
2021-12-31$94.35M$12.74M$81.60M10-K
2020-12-31$142.83M$14.61M$128.22M10-K

CBIO annual cash flow

Fiscal period endOperating cash flowCapital expenditureFinancing cash flowSEC filing
2025-12-31-$71.53M-$919.00K$322.98M10-K
2024-12-31-$31.10M-$9.97K$5.40K10-K
2023-12-31-$34.88M-$21.39K$28.82M10-K
2022-12-31-$46.46M-$84.19K$4.16M10-K
2021-12-31-$57.49M-$14.94K$10.72M10-K
2020-12-31-$39.24M-$68.51K$18.14M10-K